Polycystic ovary syndrome therapeutic (Evotec/Bayer/Celmatix)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePolycystic ovary syndrome therapeutic (Evotec/Bayer/Celmatix)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPolycystic Ovary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvotec SE
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelmatix IncBayer AGEvotec SE
Active IndicationsN/A
Inactive IndicationsPolycystic Ovary Syndrome

Other Information

ATC CodeN/A
Related LinksN/A